- $438.47m
- $847.57m
- $1.92bn
- 50
- 82
- 60
- 69
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,898 | 1,850 | 2,296 | 2,223 | 1,922 |
Cost of Revenue | |||||
Gross Profit | 435 | 412 | 580 | 490 | 245 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 1,769 | 1,720 | 2,028 | 2,052 | 1,954 |
Operating Profit | 129 | 130 | 268 | 171 | -31.8 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 105 | 101 | 258 | 170 | -19.5 |
Provision for Income Taxes | |||||
Net Income After Taxes | 78.2 | 84.7 | 198 | 136 | 2.9 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 49.2 | 55.2 | 127 | 90.2 | -12.1 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 49.2 | 55.2 | 127 | 90.2 | -12.1 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.84 | 1.61 | 4.05 | 3.6 | -0.381 |
Dividends per Share |